InSysBio to share the news from QSPC2020 management

events
Conference
March 10, 2020

March 10, 2020

Today we have received the concerning news from QSPC2020 organizers about the cancellation of the conference in response to COVID-19 outbreak continuation. Quantitative Systems Pharmacology Conference 2020 was planned to be held in April 22-24, 2020 Leiden, The Netherlands. InSysBio team was prepared to present 10 posters within the frames of the conference, namely:

  • “Investigation of bell-shaped dose response of bispecific T-cell engaging antibodies under physiological conditions: blinatumomab case study” by Oleg Demin Jr
  • “Physiologically based pharmacokinetic and receptor occupancy (PBPK/RO) modeling of anti-PD1 monoclonal antibodies” by Dmitry Shchelokov, Oleg Demin Jr
  • “CYTOCON DB as a tool to collect, compare and visualize available data on immune cells and cytokine concentrations in humans” by Ekaterina Mogilevskaya
  • “Exploration of structural differences between mechanism-based PK/PD and QSP models” by Oleg Demin
  • “Method to describe multiple effects of regulatory molecules on cell dynamics process in QSP models of immune response” by Oleg Demin
  • “QSP modeling of Combination of Radiotherapy and Immunotherapy in Pancreatic Ductal Adenocarcinoma” by Svetlana Rubina, Oleg Demin
  • “Stimulation of erythropoiesis with ESA or blood donation: QSP model” by Alexander Stepanov
  • “The development and management of Quantitative Systems Pharmacology modeling platforms using “Heta compiler”” by Evgeny Metelkin
  • “Investigation of combination therapy by quantitative systems pharmacology model of Alzheimer’s disease” by Tatiana Karelina
  • “Immune Response Template: Pre-calibrated Immune System Model for Quantitative Systems Pharmacology Development Needs” by Veronika Musatova

Still, the posters are going to be published on our website.
InSysBio team is appreciative of the organizers’ effort and their contribution to the international safety maintenance. We are looking forward to participating in QSPC next spring!

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative approach has already become a part of the drug development process implemented by our strategic partners: nowadays there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. The company has published multiple scientific studies in various therapeutic areas. InSysBio team is developing software and tools for QSP and continuously improves methods for biological modeling. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

March 2024
MoTuWeThFrSaSu
    
1
2
3
4
5
6
1. 06 Mar 2024 12:40 InSysBio to present posters at ASCPT 2024 Annual Meeting InSysBio announces its participation in the ASCPT 2024 Annual Meeting which is to be held March 27-29, at the Broadmoor in Colorado Springs, CO. Tatiana Karelina, Head of Neurodegenerative Diseases modeling team, and Vladislav Leonov, CYTOCON DB team, will present 4 posters by InSysBio
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Upcoming Events
27.03
InSysBio to present posters at ASCPT 2024 Annual Meeting
Tags
Latest News
22.02
14th InSysBio’s Annual Internal Scientific Meeting
24.01
InSysBio to present the new Plugin for Sublime Text and Heta compiler Online
07.12
InSysBio to release public beta of fIVE Calculator
06.04
InSysBio to release Immune Response Template 3.6.2 for QSP modeling
16.01
InSysBio team to publish the new article “Receptor occupancy assessment and interpretation in terms of quantitative systems pharmacology: nivolumab case study”